Goldman Sachs’s Metacrine, Inc. Common Stock MTCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-15,744
| Closed | -$10K | – | 5955 |
|
|
2022
Q1 | $10K | Sell |
15,744
-194,691
| -93% | -$124K | ﹤0.01% | 5680 |
|
|
2021
Q4 | $142K | Buy |
210,435
+194,694
| +1,237% | +$131K | ﹤0.01% | 5110 |
|
|
2021
Q3 | $54K | Sell |
15,741
-9,562
| -38% | -$32.8K | ﹤0.01% | 5176 |
|
|
2021
Q2 | $96K | Buy |
25,303
+14,694
| +139% | +$55.7K | ﹤0.01% | 5130 |
|
|
2021
Q1 | $66K | Sell |
10,609
-8,431
| -44% | -$52.5K | ﹤0.01% | 5101 |
|
|
2020
Q4 | $150K | Sell |
19,040
-79,060
| -81% | -$623K | ﹤0.01% | 4364 |
|
|
2020
Q3 | $1M | Buy |
+98,100
| New | +$1M | ﹤0.01% | 3307 |
|